Broad promises about energy, recovery or healthy aging need a specific product, outcome and evidence before they become useful treatment claims.
Turn a broad goal into an answerable question
Energy, recovery and healthy aging can mean many things. Ask what symptom or measurable outcome the proposed product is meant to change. Persistent fatigue or a new functional problem may need assessment rather than an assumption that a wellness product is the solution.
A catalog can describe options without proving that each addresses the cause of a person’s symptoms. The starting point is a clear concern and an appropriate clinical evaluation, not the most appealing product name.
A mechanism is the beginning of a hypothesis
NAD+ participates in cellular processes, and sermorelin has a hormone-signaling rationale in the provider’s description. Those facts do not independently establish better sleep, improved focus or longer life from a particular compounded program.[source]
Ask whether the evidence concerns the exact preparation and route, or a different product, laboratory model or biological marker. A nasal spray cannot simply borrow evidence from an injection or an oral precursor. The clinical outcome needs its own support.
Quality questions are route-specific
Injectable products require attention to sterile preparation. FDA’s NAD+ advisory describes adverse-event reports and concerns about ingredients unsuitable for sterile compounding. It does not identify CoreAge Rx as the subject, but it is relevant to the category.[source]
Ask for the dispensing pharmacy, storage and delivery requirements, and how concerns are handled. A needle-free option has different practical considerations; it should not be called equally effective or risk-free merely because it is more convenient.
For supplements, inspect the full label
NIH ODS recommends discussing supplements with healthcare professionals and explains that they can interact with medicines. Read the actual Supplement Facts panel rather than relying on an ingredient headline. Serving size, amounts and testing information affect the comparison.[source]
Probiotic research is strain- and outcome-specific. Creatine has research in particular exercise settings. Neither fact proves every marketed metabolic or recovery claim for a blend or a finished brand. Keep the scope of the research attached to the claim.[source][source]
Make uncertainty part of informed choice
Ask what benefit is reasonably expected, what evidence is missing, what risks or interactions matter and when the plan should be reviewed. The answer should be more specific than “supports wellness.” A clinician can also discuss alternatives with stronger support for a defined problem.
Our product reviews identify these gaps without inventing clinical results. CoreAge Rx’s sponsored position does not convert a mechanism into a proven outcome. Read the evidence guide for the same framework across all categories.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- FDA: ingredients suitable for sterile compoundingAgency reports about NAD+ injectable drugs; not a finding specific to CoreAge Rx
- NIH ODS: dietary supplements, what you need to knowRegulation, interactions, quality and evidence
- NIH ODS: probioticsStrain-specific evidence and supplement-label considerations
- NIH ODS: exercise and athletic performance supplementsIngredient research, not an evaluation of Strong Suit